208 related articles for article (PubMed ID: 19127260)
21. [Adjuvant regional chemotherapy in resected advanced pancreas carcinoma].
Gansauge F; Link KH; Rilinger N; Kunz R; Beger HG
Chirurg; 1996 Apr; 67(4):362-5. PubMed ID: 8646922
[TBL] [Abstract][Full Text] [Related]
22. Adjuvant therapy in pancreatic cancer.
Thomas A; Dajani K; Neoptolemos JP; Ghaneh P
Dig Dis; 2010; 28(4-5):684-92. PubMed ID: 21088421
[TBL] [Abstract][Full Text] [Related]
23. Conclusions from the European Study Group for Pancreatic Cancer adjuvant trial of chemoradiotherapy and chemotherapy for pancreatic cancer.
Ghaneh P; Neoptolemos JP
Surg Oncol Clin N Am; 2004 Oct; 13(4):567-87, vii-viii. PubMed ID: 15350935
[TBL] [Abstract][Full Text] [Related]
24. [Adjuvant therapy of pancreatic carcinoma].
Oettle H; Arnold D; Riess H
Praxis (Bern 1994); 2000 Nov; 89(48):2017-25. PubMed ID: 11142141
[TBL] [Abstract][Full Text] [Related]
25. Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts.
Link KH; Leder G; Formentini A; Fortnagel G; Kornmann M; Schatz M; Beger HG
Gan To Kagaku Ryoho; 1999 Jan; 26(1):10-40. PubMed ID: 9987495
[TBL] [Abstract][Full Text] [Related]
26. A randomised phase II trial of weekly high-dose 5-fluorouracil with and without folinic acid and cisplatin in patients with advanced biliary tract carcinoma: results of the 40955 EORTC trial.
Ducreux M; Van Cutsem E; Van Laethem JL; Gress TM; Jeziorski K; Rougier P; Wagener T; Anak O; Baron B; Nordlinger B;
Eur J Cancer; 2005 Feb; 41(3):398-403. PubMed ID: 15691639
[TBL] [Abstract][Full Text] [Related]
27. Phase III trial of postoperative cisplatin, interferon alpha-2b, and 5-FU combined with external radiation treatment versus 5-FU alone for patients with resected pancreatic adenocarcinoma -- CapRI: study protocol [ISRCTN62866759].
Knaebel HP; Märten A; Schmidt J; Hoffmann K; Seiler C; Lindel K; Schmitz-Winnenthal H; Fritz S; Herrmann T; Goldschmidt H; Krempien R; Mansmann U; Debus J; Diehl V; Büchler MW
BMC Cancer; 2005 Apr; 5():37. PubMed ID: 15826316
[TBL] [Abstract][Full Text] [Related]
28. Costs incurred by patients undergoing advanced colorectal cancer therapy. A comparison of raltitrexed and fluorouracil plus folinic acid.
Sculpher M; Palmer MK; Heyes A
Pharmacoeconomics; 2000 Apr; 17(4):361-70. PubMed ID: 10947491
[TBL] [Abstract][Full Text] [Related]
29. Long-term results of 2 adjuvant trials reveal differences in chemosensitivity and the pattern of metastases between colon cancer and rectal cancer.
Kornmann M; Staib L; Wiegel T; Kron M; Henne-Bruns D; Link KH; Formentini A;
Clin Colorectal Cancer; 2013 Mar; 12(1):54-61. PubMed ID: 23107590
[TBL] [Abstract][Full Text] [Related]
30. Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer: Final Results of the NO16968 Randomized Controlled Phase III Trial.
Schmoll HJ; Tabernero J; Maroun J; de Braud F; Price T; Van Cutsem E; Hill M; Hoersch S; Rittweger K; Haller DG
J Clin Oncol; 2015 Nov; 33(32):3733-40. PubMed ID: 26324362
[TBL] [Abstract][Full Text] [Related]
31. Long-term survival results of surgery alone versus surgery plus 5-fluorouracil and leucovorin for stage II and stage III colon cancer: pooled analysis of NSABP C-01 through C-05. A baseline from which to compare modern adjuvant trials.
Wilkinson NW; Yothers G; Lopa S; Costantino JP; Petrelli NJ; Wolmark N
Ann Surg Oncol; 2010 Apr; 17(4):959-66. PubMed ID: 20082144
[TBL] [Abstract][Full Text] [Related]
32. Weekly 24-h infusion of high-dose 5-fluorouracil (5-FU) with folinic acid (FA) in adjuvant therapy of colon cancer.
Wein A; Riedel C; Brückl W; Kastl S; Reingruber B; Hohenberger W; Hahn EG
Z Gastroenterol; 2001 Feb; 39(2):153-6. PubMed ID: 11253506
[TBL] [Abstract][Full Text] [Related]
33. A randomized phase III trial of adjuvant chemotherapy with irinotecan, leucovorin and fluorouracil versus leucovorin and fluorouracil for stage II and III colon cancer: a Hellenic Cooperative Oncology Group study.
Papadimitriou CA; Papakostas P; Karina M; Malettou L; Dimopoulos MA; Pentheroudakis G; Samantas E; Bamias A; Miliaras D; Basdanis G; Xiros N; Klouvas G; Bafaloukos D; Kafiri G; Papaspirou I; Pectasides D; Karanikiotis C; Economopoulos T; Efstratiou I; Korantzis I; Pisanidis N; Makatsoris T; Matsiakou F; Aravantinos G; Kalofonos HP; Fountzilas G
BMC Med; 2011 Jan; 9():10. PubMed ID: 21281463
[TBL] [Abstract][Full Text] [Related]
34. Adjuvant therapy in pancreatic cancer: a critical appraisal.
Oettle H; Neuhaus P
Drugs; 2007; 67(16):2293-310. PubMed ID: 17983252
[TBL] [Abstract][Full Text] [Related]
35. Adjuvant therapy in pancreatic cancer: historical and current perspectives.
Neoptolemos JP; Cunningham D; Friess H; Bassi C; Stocken DD; Tait DM; Dunn JA; Dervenis C; Lacaine F; Hickey H; Raraty MG; Ghaneh P; Büchler MW
Ann Oncol; 2003 May; 14(5):675-92. PubMed ID: 12702520
[TBL] [Abstract][Full Text] [Related]
36. Effect of adjuvant capecitabine or fluorouracil, with or without oxaliplatin, on survival outcomes in stage III colon cancer and the effect of oxaliplatin on post-relapse survival: a pooled analysis of individual patient data from four randomised controlled trials.
Schmoll HJ; Twelves C; Sun W; O'Connell MJ; Cartwright T; McKenna E; Saif M; Lee S; Yothers G; Haller D
Lancet Oncol; 2014 Dec; 15(13):1481-1492. PubMed ID: 25456367
[TBL] [Abstract][Full Text] [Related]
37. High-dose folinic acid and fluorouracil with or without ifosfamide is an inactive combination in advanced pancreatic cancer. A randomized phase II study of the Italian Oncology Group for Clinical Research (G.O.I.R.C.).
Di Costanzo F; Tagliaventi M; Carlini P; Zironi S; Mazzocchi B; Bella M; Donati D; Acito L; Maggian P; Angiona S
Am J Clin Oncol; 1996 Jun; 19(3):307-10. PubMed ID: 8638548
[TBL] [Abstract][Full Text] [Related]
38. Adjuvant radio-chemotherapy in stage II-III rectal cancer with 24-hour infusion of high-dose 5-fluorouracil and folinic acid: evaluation of feasibility.
Dencausse Y; Sturm J; Hartung G; Dietzler P; Edler L; Bambach M; Wojatschek C; Lindemann H; Qeisser W
Onkologie; 2001 Oct; 24(5):476-80. PubMed ID: 11694775
[TBL] [Abstract][Full Text] [Related]
39. A systematic overview of chemotherapy effects in colorectal cancer.
Ragnhammar P; Hafström L; Nygren P; Glimelius B;
Acta Oncol; 2001; 40(2-3):282-308. PubMed ID: 11441937
[TBL] [Abstract][Full Text] [Related]
40. Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer.
Haller DG; Tabernero J; Maroun J; de Braud F; Price T; Van Cutsem E; Hill M; Gilberg F; Rittweger K; Schmoll HJ
J Clin Oncol; 2011 Apr; 29(11):1465-71. PubMed ID: 21383294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]